Based on our observations in Fig. 1, it is also likely that other factors exist that can increase PRC2 activity at the PTEN promoter independently of NOTCH1 and NOTCH2 pathway activity, as well as PRC2-independent mechanisms of PTEN repression in breast cancer. This evidence concerns the gene PTEN and breast cancer.